HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Two-port pars plana vitrectomy surgery: a prospective interventional case series.

AbstractBACKGROUND AND OBJECTIVE:
Current literature review fails to disclose any series describing the use of two-port vitrectomy in adult patients. This study was performed to determine the feasibility and efficacy of pars plana vitrectomy surgery using two (rather than three or four)-port access for treatment of diabetic patients with nonclearing vitreous haemorrhage due to retinal neovascularization.
DESIGN:
Interventional prospective case series: to measure ability to allow for long-term resolution of chronic uncomplicated vitreous haemorrhage in diabetic patients, and to study the frequency and nature of complications associated with this technique.
METHODS:
Two-port pars plana vitrectomy (with endolaser treatment and membrane delamination if necessary) was performed in a prospective series of 12 consecutive diabetic patients with nonclearing vitreous haemorrhage due to retinal neovascularization.
RESULTS:
Successful removal of vitreous haemorrhage resulted in all patients. No visually significant intraoperative complications occurred. Best postoperative visual acuity correlated with lenticular and macular perfusion status.
CONCLUSION:
Two-port pars plana vitrectomy is an efficient (and potentially safer and faster) alternative to the standard three-port vitrectomy in selected patients.
AuthorsM Colucciello
JournalEye (London, England) (Eye (Lond)) Vol. 19 Issue 8 Pg. 869-72 (Aug 2005) ISSN: 0950-222X [Print] England
PMID15359245 (Publication Type: Evaluation Study, Journal Article)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Chronic Disease
  • Diabetic Retinopathy (complications, physiopathology, surgery)
  • Feasibility Studies
  • Humans
  • Middle Aged
  • Prospective Studies
  • Treatment Outcome
  • Visual Acuity
  • Vitrectomy (methods)
  • Vitreous Hemorrhage (etiology, physiopathology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: